Vineet Laboratories Past Earnings Performance
Past criteria checks 0/6
Vineet Laboratories's earnings have been declining at an average annual rate of -23.2%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 44.6% per year.
Key information
-23.2%
Earnings growth rate
-21.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | -44.6% |
| Return on equity | -13.3% |
| Net Margin | -3.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vineet Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,134 | -41 | 65 | 0 |
| 30 Jun 24 | 1,377 | 1 | 65 | 0 |
| 31 Mar 24 | 1,510 | 10 | 65 | 0 |
| 31 Dec 23 | 1,708 | 27 | 62 | 0 |
| 30 Sep 23 | 2,049 | 61 | 64 | 0 |
| 30 Jun 23 | 2,009 | -10 | 62 | 0 |
| 31 Mar 23 | 2,123 | 13 | 61 | 0 |
| 31 Dec 22 | 2,107 | 10 | 56 | 0 |
| 30 Sep 22 | 1,823 | 10 | 47 | 0 |
| 30 Jun 22 | 1,823 | 64 | 46 | 0 |
| 31 Mar 22 | 1,912 | 66 | 58 | 0 |
| 31 Mar 21 | 2,435 | 18 | 56 | 0 |
Quality Earnings: 543298 is currently unprofitable.
Growing Profit Margin: 543298 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543298 is unprofitable, and losses have increased over the past 5 years at a rate of 23.2% per year.
Accelerating Growth: Unable to compare 543298's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 543298 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.5%).
Return on Equity
High ROE: 543298 has a negative Return on Equity (-13.33%), as it is currently unprofitable.